NCT07361042

Brief Summary

The goal of this study is to evaluate the performance of the new video laryngeal masks for securing airway in patients undergoing general anaesthesia. Main goal is to evaluate the first insertion attempt success rate, time to adequate ventilation, sealing pressures and adverse events.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
417

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Apr 2026Sep 2027

First Submitted

Initial submission to the registry

January 5, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

1.4 years

First QC Date

January 5, 2026

Last Update Submit

February 27, 2026

Conditions

Keywords

supraglottic airwaylaryngeal maskairway management

Outcome Measures

Primary Outcomes (1)

  • Sealing pressure

    The maximum sealing pressure that can be reach after insertion and optimal alignment of the laryngeal mask. The APL ventilator will be set to 70 mbar and after there will be plateau on the pressure curve the sealing pressure will be measured.

    After achieving adequate ventilation, and at 10 and 20 minutes thereafter.

Secondary Outcomes (1)

  • Time to adequate ventilation

    From initiation of the first insertion attempt through the end of general anesthesia, up to 6 hours.

Other Outcomes (1)

  • First insertion attempt success rate

    From initiation of the first insertion attempt through the end of general anesthesia, up to 6 hours.

Study Arms (3)

Video Laryngeal Mask

EXPERIMENTAL

This arm will have airway secured with SaCo video laryngeal mask.

Device: Video Laryngeal Mask SaCo VLM

Laryngeal Mask Supreme

ACTIVE COMPARATOR

This group will have airway secured with traditional Supreme laryngeal mask.

Device: Laryngeal Mask Supreme

Laryngeal Mask Ambu

ACTIVE COMPARATOR

Laryngeal Mask Ambu Aura Gain

Device: Laryngeal Mask Ambu Aura Gain

Interventions

Standard laryngeal mask Supreme will be used for airway management.

Also known as: Supreme, laryngeal mask
Laryngeal Mask Supreme

Video laryngeal mask third generation SaCoVLM will be used for airway management.

Also known as: VLMA, Video laryngeal mask
Video Laryngeal Mask

Laryngeal Mask Ambu Aura Gain will be used in this group for airway management.

Laryngeal Mask Ambu

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient without predicted difficult airway (MACOCHA score ≤ 2), undergoing a planned surgical procedure under general anesthesia with an indication for airway management using a laryngeal mask.
  • Patient aged 18 years or older.

You may not qualify if:

  • Patient younger than 18 years.
  • Patient with predicted difficult airway (MACOCHA score \> 2).
  • Patient with a history of difficult airway.
  • Patient requiring airway management with a method other than a laryngeal mask.
  • Refusal or failure to sign the informed consent for study participation. • Patient undergoing emergency surgery.
  • Administration of muscle relaxants for LMA insertion.
  • State Entropy value below 30 during LMA insertion.
  • State Entropy value above 60 during LMA insertion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Laryngeal Masks

Intervention Hierarchy (Ancestors)

Intubation, IntratrachealAirway ManagementTherapeuticsIntubationInvestigative TechniquesMasksProtective DevicesEquipment and SuppliesPersonal Protective EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Michal Kalina

    Masaryk Hospital Ústí nad Labem Czech Republic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michal Kalina, MUDr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy for science and research

Study Record Dates

First Submitted

January 5, 2026

First Posted

January 22, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data will be store in the depository of University of Jan Evangelista Purkynje in Ústí nad Labem.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
The data will be shared in the university repository for five years after completion of the study.
Access Criteria
Data will be public in the University depositroy.